Rolling out new anti-tuberculosis drugs without diagnostic capacity

Deaths from tuberculosis (TB) reached over 1.6 million in 2021 with 10.6 million people becoming ill. Multidrug-resistant TB, defined as the Mycobacterium tuberculosis organism having resistance to at least isoniazid and rifampicin, represented 3.9% of new TB cases and 18% of previously treated case...

Descripción completa

Detalles Bibliográficos
Autores principales: Ness, Tara, Van, Le Hong, Petermane, Ilze, Duarte, Raquel, Lange, Christoph, Menzies, Dick, Cirillo, Daniela Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365078/
https://www.ncbi.nlm.nih.gov/pubmed/37492347
http://dx.doi.org/10.1183/20734735.0084-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365078/
https://www.ncbi.nlm.nih.gov/pubmed/37492347
http://dx.doi.org/10.1183/20734735.0084-2023

Ejemplares similares